NCT05529615View on ClinicalTrials.gov

Circulating Tumor DNA Guided Adjuvant Chemotherapy for Colon Cancer

NARecruitingINTERVENTIONAL
Enrollment

2,684

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

May 1, 2029

Study Completion Date

May 1, 2029

Conditions
Colon CancerCirculating Tumor DNA
Interventions
PROCEDURE

detection of ctDNA

the ctDNA will be detected during the treatment and served as the andomization basis

Trial Locations (1)

100142

RECRUITING

Peking university cancer hospital, Beijing

All Listed Sponsors
lead

Peking University Cancer Hospital & Institute

OTHER